On the front page...
President Bush's budget request for NIH in fiscal
year 2007, announced Feb. 6, totals $28.587 billion, the same budget
level as FY 2006.
Viewed in perspective, the FY 06 budget itself was
notable as the first time since 1970 that NIH had a reduction in
dollars relative to the year before. The bottom line for FY 06
stands at about $60 million below that of FY 2005.
The FY 2007 President's request is therefore 0.2
percent below FY 05 and equal to FY 06.
Emphases within the President's 2007 budget include funding for
several trans-NIH strategic initiatives: biodefense; enhanced support
for new investigators; the NIH Roadmap for Medical Research; the
Genes and Environment Initiative; the Clinical and Translational
Sciences Award program; management innovations; and pandemic influenza.
In the field of biodefense, the budget calls for $1.891 billion,
an increase of $110 million and 6.2 percent over FY 06. Within
this increase, NIH will direct $160 million to an advanced development
fund supporting efforts to work with academia and industry to develop
candidate countermeasures from the point of investigational new
drug applications to the level that these might qualify for acquisition
by Project BioShield.
NIH will invest $15 million in a new "Pathway to Independence" program
to provide increased support for new investigators (see NIH
Feb. 10, 2006).
The Roadmap for Medical Research has three themes: New Pathways
to Discovery (slated for $181 million); Multidisciplinary Research
Teams of the Future (to receive $81 million); and Re-engineering
the Clinical Research Enterprise ($181 million). NIH will direct
a total of $443 million towards Roadmap initiatives, an increase
of $113 million over the FY 06 appropriation. This total arises
from a $111 million contribution from the NIH Director's Discretionary
Fund and $332 million contributed by the NIH institutes and centers.
The IC contributions represent 1.2 percent of each individual budget
request for FY 07.
NIH also allocated $40 million to the ICs to support a Genes and
Environment Initiative, a multi-year plan to identify major genetic
susceptibility factors for common diseases like heart disease,
stroke, osteoarthritis, cancer, diabetes, and Alzheimer's disease,
while developing technologies to assess risk factors in diet, physical
activity, and environmental exposure. This plan was announced Feb.
8 at a joint press conference held by NHGRI and NIEHS (see story).
The Clinical and Translational Sciences Award program will combine
existing NIH programs such as the General Clinical Research Centers
in the National Center for Research Resources, as well as Roadmap
initiatives in the Re-engineering the Clinical Research theme.
Several full awards, as well as planning grants in FY 06 and 07
will increase as existing GCRCs complete current funding cycles
and recompete these transformational awards. The FY 07 budget for
this combined program is estimated to be $361 million.
NIH will improve the management of its biomedical and behavioral
research portfolio. The newly formed Office of Portfolio Analysis
and Strategic Initiatives will develop methods to assist the agency
in assessing its large and complex portfolio, coordinate trans-NIH
evaluation efforts and provide a transparent process for identifying
important scientific initiatives that cut across or fall between
missions of institutes and centers.
A link to a summary of the FY 07 President's budget can be found
on the NIH home page under Medical Research Issues.